How the Treatment Paradigm for EGFR+ Lung Cancer Will Transform

November 27, 2017
Justin F. Gainor, MD

Justin F. Gainor, MD, medical oncologist, Assistant Professor of Medicine, Massachusetts General Hospital, Harvard Medical School, discusses how the treatment paradigm for EGFR+ lung cancer will transform over the next several years.